Dr Lal PathLabs: निवेशकों को 1 शेयर पर ₹12.00 की अतिरिक्त कमाई:
Dr Lal PathLabs: 1 शेयर पर ₹12.00 अंतरिम डिविडेंड

#DrLalPathLabs #Dividend #beyourmoneymanager #बीयोरमनीमैनेजर #shortsvideo #stockmarket #shortvideo @beyourmoneymanager @beyourmoneymanagerMarathi

Dr Lal PathLabs: 1 शेयर पर ₹6.00 की अतिरिक्त कमाई
Dr Lal PathLabs: 1 शेयर पर ₹6.00 अंतिम डिविडेंड
#DrLalPathLabs #dividend #beyourmoneymanager @DrLalPathLabs @beyourmoneymanager @beyourmoneymanagerMarathi

Anyone watching this??

DRLALPATHLABS

#stockmarket #optiontrading #stockoptions #nifty #banknifty

#DrlalPathLabs - Volume contraction and tight range
Disc: Holding

Increased homocysteine levels may indicate deficiencies in vitamins B6, B12, or folate and may lead to heart disease, stroke, & other health problems. Regular monitoring may reduce the cardiovascular risk & improve overall health.

#KnowYourTest #Homocysteine #DrLalPathlabs

Dr Lal Pathlabs Ltd #DrLalPathlabs
Showing good growth in sales and profits.
Looks good for 29% gain with #RHSStrategy

#stockmarket #nifty #sensex #investing #trading #nse #indianstockmarket #investment #finance #money #investor #nifty 50 #business #Equity #sharemarket

#DrLalPathlabs ' Q2 revenue at Rs 601 crore, up 12.6% year-on-year.

Dr Lal Pathlabs Result

-YoY ↑
-QoQ ↑

#banknifty #Nifty #Nifty Bank #nifty50 #stockmarketcrash #midcapnifty #smallcap #SmallCaps #DrLalPathlabs

Pick of the week
BUY – Dr Lal Path Labs

#DrLalPathLabs #nifty 50 #stocks #sensex #nifty #stockinfocus #stockmarketnews #sharemarketnews #stocks #sharemarketindia #investing #investor #blinkX #getblinkX

Dr. Lal PathLabs Ltd.
#DrLalPathLabs #Q4Results #StockMarketNews
Dr Lal PathLabs

DrLalPathLabs' December quarter net profit at Rs 82.2 crore, up 53.4% year-on-year.

Stock of the day - #Drlalpathlabs

💎 DR LAL PATH LABS

- CMP : 2260
- B.O Done from Trendline Resistance
- W formation in play
- Rising Volumes Intake
- Seems legit for 2600-2800

🔭 Keep it on radar.

#stockstowatch #stockmarkets #investing #trading #drlalpathlabs

Dr Lal Pathlabs

#LALPATHLAB #DRLALPATHLABS
#Q2FY24 #q2 results #results #earnings #q2 #Q2withTenshares #Tenshares

Dr Lal Pathlabs

#LalPathlab s #LalPathlab #DrLalPathlabs
#Q4FY24 #q4 results #results #earnings #q4 #Q4withTenshares #Tenshares

#EarningsWithSwadesh | #DrLalPathLabs ने पेश किए मार्च तिमाही (Q4) के नतीजे (YoY)

- कंसो मुनाफा 50.8% बढ़कर ₹86 करोड़
- कंसो आय 11.1% बढ़कर ₹545 करोड़
- कंसो EBITDA 25.2% बढ़कर ₹145 करोड़
- EBITDA मार्जिन 23.5% से बढ़कर 26.5%
- ₹6/Sh डिविडेंड का ऐलान

#Q4WithSwadesh

Dr. Lal Pathlabs: Mr. Bharath U, Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) of the Company has resigned from the services of the Company
#drlalpathlabs #ceo

Dr Lal Pathlabs में हो रहा है नुकसान, क्या करें ?

Vipin Bhatt Sarvendra Srivastava #Sensex #sharemarket #sharemarket newstoday #sharemarket today #stockmarket #sharebazar #nifty #banknifty #sharemarket india #StocksToWatch #StocksInFocus #StocksInNews #DrLalPathLabs

Dr Lal Pathlabs

#LALPATHLAB #DrLalPathlab s #DrLalPathlab
#Q4FY23 #q4 results #results #earnings #q4 #Q4withTenshares #Tenshares

#DRLALPATHLABS
🐂
PRICE WISE CORRECTION OVER
TIME WISE CORRECTION PENDING

🐻SUPPORT 1810/2068

📈RESISTANCE 2600/3379

COMING TARGET/3YEAR🎯
2592 2850 3260 3639 3938 4243

#APOLLOHOSPITAL #SHALBY #MAXHEALTHCARE

#NSE #BSE #SENSEX #GIFTNIFTY
#COMMODITIES #BANKNIFTY #SILVER